Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
san diego blog main
san diego top stories
4
×
clinical trials
fda
boston blog main
boston top stories
national top stories
new york blog main
san diego
san francisco blog main
startups
achaogen
acute myeloid leukemia
adams street partners
adverum biotechnologies
aimmune therapeutics
allergy
ambit biosciences
anaphylaxis
andrew oxtoby
antibiotics
athena countouriotis
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
biotech ipos
boston
boulder/denver blog main
boulder/denver top stories
brett zbar
bristol-myers squibb
cormorant asset management
daiichi sankyo
daniel edelman
deals
detroit blog main
detroit top stories
drug resistance
What
drug
4
×
therapeutics
4
×
company
medicines
million
raised
year
agency
aimmune
allergy
approval
approved
athena
awarded
bacteria
biopharma
biotech
brings
business
cancer
ceo
chief
countouriotis
developed
developing
disease
disorders
dyne
dyne’s
exited
fda
fighting
financing
friday
genetic
gets
immunotherapy
infections
infectious
ipo
Language
unset
Current search:
drug
×
" san diego top stories "
×
therapeutics
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
